References
Landis JR, Kock GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Walters BC (1998) Clinical practice parameter development in neurosurgery. In: Bean J (ed) Neurosurgery in transition: the socioeconomic transformation of neurological surgery. Williams and Wilkins, Baltimore, pp 99–111
Amundsen P, Dugstad G, Syvertsen AH (1978) The reliability of computer tomography of the diagnosis and differential diagnosis of meningiomas, gliomas and brain metastases. Acta Neurochir 41:177–190
Dadparvar S, Krishna L, Miyamoto C et al (1994) Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas. Cancer 73:884–889
Prat-Acin R, Diaz-Vicente FJ, Banzo-Marraco J et al (1997) Histological prediction of cerebral tumors using SPECT with 201Tl. Rev Neurol 25:1168–1170
Oriuchi N, Tamura M, Shibazaki T et al (1991) Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity. Japanese Journal of Nuclear Medicine 28:1263–1271
Taki S, Kakuda K, Kakuma K (1999) 201Tl SPET in the differential of brain tumours. Nucl Med Commun 20:637–645
Dean BL, Drayer BP, Bird CR et al (1990) Gliomas: classification with MR imaging. Radiology 174:411–415
Sugahara T, Korogi Y, Kochi M et al (1998) Correlation of MR imaging—determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Radiol 171:1479–1486
Lev MH, Ozsunar Y, Henson JW, Rasheed AA et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. Am J Neuroradiol 25:214–221
Ketonen L (1978) Computerized tomography for diagnosis of supratentorial tumors. Acta Neurol Scand Suppl 67:153–164
Choksey MS, Valentine A, Shawdon H et al (1989) Computed tomography in the diagnosis of malignant brain tumours: do all patients require biopsy? J Neurol Neurosurg Psychiatr 52:821–825
Katano H, Karasawa K, Sugiyama N et al (2002) Comparison of thallium-201 uptake and retention indices for evaluation of brain lesions with SPECT. J Clin Neurosci 9:653–658
Black KL, Emerick T, Hoh C et al (1994) Thallium-201 SPECT and positron tomography equal predictors of gliomas grade and recurrence. Neurol Res 16:93–96
Igase K, Oka Y, Ohta S et al (2002) Usefulness of thallium-201 single photon emission computed tomography to quantify the malignancy grade of brain tumors. Neurol Med Chir (Tokyo) 36:434–439
Baillet G, Albuquerque L, Chen Q et al (1994) Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21:1061–1066
Sjoholm H, Elmqvist D, Rehncrona S et al (1995) SPECT imaging of gliomas with thallium-201 and technetium-99m-HMPAO. Acta Neurol Scand 91:66–70
Reimann B, Papke K, Hoess N et al (2002) Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-l-α-methyltyrosine SPECT. Radiology 225:567–574
Debelke D, Meyerowitz C, Lapidus RL et al (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47–52
Bell D, Grant R, Collie D et al (2002) How well do radiologists diagnose intracerebral tumor histology on CT? Findings from a prospective multicentre study. Br J Neurosurg 16:573–577
Negendank WG, Sauter R, Brown TR et al (1996) Magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449–458
Carapella CM, Carpinelli G, Knijn A et al (1997) Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumors. Acta Neurochir Suppl 68:127–132
Tamiya T, Kinoshita K, Ono Y et al (2000) Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42:333–338
Howe FA, Barton SJ, Cudlip SA et al (2003) Metabolic profiles of human brain tumors using quantitative in vivo magnetic resonance 1H spectroscopy. Magn Reson Med 49:223–232
Moller-Hartmann W, Herminghaus S, Krings T et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381
Lee SJ, Kim JH, Kim YM et al (2001) Perfusion MR imaging in gliomas: comparison with histologic grade. Korean J Radiol 2:1–7
Shin JH, Lee HK, Kwun BD et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas. Am J Radiol 179:783–789
Roberts HC, Roberts TPL, Bollen AW et al (2001) Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grad and tumor labeling index: a study in human brain tumors. Acad Radiol 8:384–391
Beppu T, Inoue T, Shibata Y et al (2003) Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neuro-oncol 63:109–116
Kurki T, Lundbom N, Kalimo H et al (1995) MR Classification of brain gliomas: value of magnetization transfer and conventional imaging. Magn Reson Imaging 13:501–511
Uematsu H, Maeda M, Sadato N et al (2002) Measurement of the vascularity and vascular leakage of gliomas by double-echo dynamic magnetic resonance imaging. A preliminary study. Invest Radiol 37:571–576
Murphy M, Loosemore A, Clifton AG et al (2002) The contribution of proton magnetic resonance spectroscopy (1HMRS) to clinical brain tumour diagnosis. Br J Neurosurg 16:329–334
Murphy PS, Rowland IJ, Viviers L et al (2003) Could assessment of glioma methylene lipid resonance by in vivo 1H-MRS be of clinical value? Br J Radiol 76:459–463
Isobe T, Matsumura A, Anno I et al (2002) Quantification of cerebral metabolites in gliomas patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20:343–349
Poptani H, Kaartinen J, Gupta RK et al (1999) Diagnostic assessment of brain tumors and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks. J Cancer Res Clin Oncol 125:343–349
Rutter A, Hugenholtz H, Saunders JK et al (1995) One-dimensional phosphorus-31 chemical shift imaging of human brain tumors. Invest Radiol 30:359–366
Sugahara T, Korogi Y, Kochi M (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60
Castillo M, Smith JK, Kwock L et al (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22:60–64
Lam WWM, Poon WS, Metreweli C (2002) Diffusion MR imaging in glioma: does it have any role n the pre-operation determination of grading glioma? Clin Radiol 57:219–225
Acknowledgements
The authors wish to acknowledge Beverly Murphy for her expert assistance in developing a coherent literature search and Bruce Frankel, MD for his critical review and assistance in organization of the material to be presented. Additionally we wish to thank Stephen Haines, MD, Jack Rock, MD, and Tom Mikkelson, MD for their review and comments on this work. The authors also wish to express appreciation to the AANS/CNS Joint Guidelines Committee for their review, comments and suggestions. We also thank Linda Phillips for meeting organization and collection of materials and Emily Feinstein for her assistance in editing the material for publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mukundan, S., Holder, C. & Olson, J.J. Neuroradiological assessment of newly diagnosed glioblastoma. J Neurooncol 89, 259–269 (2008). https://doi.org/10.1007/s11060-008-9616-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-008-9616-3